MIL:PHIL
Philogen S.p.A. · MIL · Healthcare · EUR · FY for 2025
Figures on this page computed 2026-11-08 11:31 UTC
Last close
n/aEUR
Market data
We are not showing closes for this listing. A line drawn through points we do not hold would look exactly like a listing that did not move.
3.7xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
73.1%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
85.3%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.
- Growth131.0%97 of 100, above its sector
- Returns on capital61.4%99 of 100, above its sector
- Margins86.5%99 of 100, above its sector
- Price3.7x58 of 100, above its sector
- Safety7.7694 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales5.90x
Its own average over 9 years, 53.3M.
- Profit8.54x
Its own average over 9 years, 26.9M.
- Free cash flow9.47x
Its own average over 9 years, 28.3M.
- Debt0.73x
Its own average over 9 years, 15.0M.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at 9.47 times.
A find tonight
The earnings in its last filed year are 27.3 percent of what the whole company costs, the free cash flow it filed is 31.8 percent of its market value, and sits at 12.4 on Altman's Z, clear of the distress band.
- Value
- 70
- Cheap
- 72
- Sound
- 69
- Unwatched
- 82
What stands out
- Safety: sits at 12.4 on Altman's Z, clear of the distress band, which is better than 98 percent of the companies we rank in Italian Stock Exchange.
- Price: the earnings in its last filed year are 27.3 percent of what the whole company costs, which is better than 97 percent of the companies we rank in Italian Stock Exchange.
What could make it a trap
- Beneish's M is 0.59, above the -1.78 his model treats as worth reading the accruals for.
Why it is cheap
Except where said otherwise: Computed from the filing for 2025
Earnings yield27.3%
Filed net income for the last annual period, over market value
- Source
- computed
- Fiscal year
- 2025
- Taken on
- 2026-11-04
- Reported in
- EUR
- Computed from the FY for 2025
- Market data, 2026-11-04
Free cash flow yield31.8%
Filed operating cash flow less capital expenditure, over market value
- Source
- computed
- Fiscal year
- 2025
- Taken on
- 2026-11-04
- Reported in
- EUR
- Computed from the FY for 2025
- Market data, 2026-11-04
Price to book2.3x
Market value over filed total equity
- Source
- computed
- Fiscal year
- 2025
- Taken on
- 2026-11-04
- Reported in
- EUR
- Computed from the FY for 2025
- Market data, 2026-11-04
Cash and equivalents against market value15.1%
Filed cash and equivalents, over market value
- Source
- computed
- Fiscal year
- 2025
- Taken on
- 2026-11-04
- Reported in
- EUR
- Computed from the FY for 2025
- Market data, 2026-11-04
Altman Z-Score12.38Computed from the FY for 2025
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
Piotroski F-Score7.00Computed from the FY for 2025
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
Earnings quality (Sloan accruals)1.10Computed from the FY for 2025
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
Consecutive profitable filed years2Computed from the FY for 2025
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
Last close: Market data, 2026-11-04
The filed years, as a table
9Each line is 100 at 2017-12-31, the first year we hold.
| Filed year | Sales | Profit | Shares in issue |
|---|---|---|---|
| 2017-12-31 | 100.0 | 100.0 | 100.0 |
| 2018-12-31 | 133.1 | 148.1 | 100.0 |
| 2019-12-31 | 121.2 | 56.1 | 100.0 |
| 2020-12-31 | 45.9 | -531.4 | 100.0 |
| 2021-12-31 | 24.0 | -629.0 | 135.6 |
| 2022-12-31 | 227.8 | -215.0 | 138.2 |
| 2023-12-31 | 222.2 | -246.4 | 137.6 |
| 2024-12-31 | 710.9 | 1,811.7 | 137.8 |
| 2025-12-31 | 3,019.7 | 9,187.0 | 137.7 |
How sales was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
How profit was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
How shares in issue was got
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- EUR
Figures behind the shape
Growth
131.0%faster is higher, placed against 4,950 companies as of 2026-11-07
Five-year revenue growth rate131.0%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
One-year change in net income407.1%
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
Returns on capital
61.4%higher is higher, placed against 5,089 companies as of 2026-11-07
Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on equity61.4%
Net Income / Shareholders' Equity x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Return on assets52.5%
Net Income / Total Assets x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Margins
86.5%wider is higher, placed against 3,412 companies as of 2026-11-07
Gross margin86.5%
Gross Profit / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Operating margin80.0%
Operating Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Net margin73.1%
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Free cash flow margin85.3%
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Price
3.7xcheaper is higher, placed against 4,362 companies as of 2026-11-07
Price to earnings3.7x
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
Price to book2.3x
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
- computed
- Computed from the filing for 2025
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Price to sales ratio2.7x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
- Computed from the filing for 2025
- Computed from the filing for 2025
Safety
7.76safer is higher, placed against 3,227 companies as of 2026-11-07
Debt to equityn/a
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Current ratio7.76
Current Assets / Current Liabilities
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Interest coverage760.1x
Operating Income / Interest Expense
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
Altman Z-Score12.48
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
What it pays out
n/aWe do not hold this figure for this company, so there is nothing to place.
more, and better covered, is higher, with no cohort held
Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- EUR
- computed
Share a finding
A link to the finding, not to you: it carries nothing about your account.